NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析

GlobalDataが出版した調査資料(DATA8011198)
◆英語タイトル:NeuroMetrix Inc (NURO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011198
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS pain therapy and NC-stat DPNCheck are used for the treatment of diabetic peripheral neuropathy. NeuroMetrix has expertise in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company caters to clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through distributors in the US, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.

NeuroMetrix Inc (NURO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NeuroMetrix Inc, Medical Equipment, Deal Details 11
Partnerships 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 11
NeuroMetrix Enters into Agreement with Synovation Medical 12
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 13
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 14
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 17
Equity Offering 18
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 18
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 20
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 21
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 23
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 25
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 28
NeuroMetrix Raises USD8 Million in Private Placement of Securities 30
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 31
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 32
NeuroMetrix Inc – Key Competitors 33
NeuroMetrix Inc – Key Employees 34
NeuroMetrix Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 35
Recent Developments 36
Financial Announcements 36
Oct 19, 2017: NeuroMetrix Reports Q3 2017 Financial Results 36
Jul 20, 2017: NeuroMetrix Reports Q2 2017 Financial Results 37
Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results 38
Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results 39
Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016 40
Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results 41
Jul 21, 2016: NeuroMetrix Reports Q2 2016 Financial Results and Highlights 42
Apr 21, 2016: NeuroMetrix Reports Q1 2016 Financial Results and Highlights 43
Jan 28, 2016: NeuroMetrix Reports Q4 2015 Financial Results and Highlights 44
Jan 11, 2016: NeuroMetrix Reports Preliminary Financial Highlights for 2015 45
Corporate Communications 46
Jul 06, 2017: NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics 46
Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer 47
Product News 48
Aug 03, 2016: NeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo 48
May 26, 2016: NeuroMetrix Reports the Launch of the Quell Health Cloud for Android 49
03/17/2016: NeuroMetrix Announces Availability of Quell at Target 50
03/16/2016: Quell Named Best Wearable Technology in 2016 SXSW Interactive Innovation Awards 51
03/10/2016: NeuroMetrix Showcases Quell Wearable Pain Relief Technology at the 2016 SXSW Show 52
03/02/2016: NeuroMetrix Announces Availability of the Newest Version of Quell Wearable Pain Relief Technology 53
02/16/2016: NeuroMetrix Showcases Quell Technology at American Physical Therapy Association Meeting 54
02/10/2016: NeuroMetrix Showcases Quell Technology at the American Academy of Pain Medicine Annual Meeting 55
02/04/2016: NeuroMetrix to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference 56
02/04/2016: Quell Wearable Pain Relief Technology Selected as a Finalist in SXSW Interactive Innovation Awards 57
01/28/2016: NeuroMetrix Showcases Quell Technology at the North Carolina Foot & Ankle Society’s Winter Scientific Seminar 58
01/21/2016: NeuroMetrix Reports Regulatory Approval for DPNCheck in China 59
01/21/2016: NeuroMetrix Showcases Quell Technology at the New York Podiatric Clinical Conference 60
Product Approvals 61
Jan 21, 2016: NeuroMetrix Reports Regulatory Approval for DPNCheck in China 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
NeuroMetrix Inc, Medical Equipment, Key Facts, 2016 2
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NeuroMetrix Inc, Deals By Market, 2011 to YTD 2017 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NeuroMetrix Enters into Agreement with Fukuda Denshi 11
NeuroMetrix Enters into Agreement with Synovation Medical 12
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 13
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 14
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 17
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 18
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 20
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 21
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 23
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 25
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 28
NeuroMetrix Raises USD8 Million in Private Placement of Securities 30
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 31
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 32
NeuroMetrix Inc, Key Competitors 33
NeuroMetrix Inc, Key Employees 34
NeuroMetrix Inc, Joint Venture 35

★調査レポート[NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析] (コード:DATA8011198)販売に関する免責事項を必ずご確認ください。
★調査レポート[NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆